Skip to content
PatentBrief
Get alertsTop ↑

How Felix Hoffmann Invented Aspirin

The 1900 patent for acetylsalicylic acid, the chemical compound that became the world's most common pain reliever, known as Aspirin.

Granted 1900ExpiredExpired 1918Owned by FARBENFABRIKEN OF ELBERFELD CoInvented by Felix Hoffmann

Original patent title: “Acetyl salicylic acid.

Plain-English explanation by SahiLast reviewed · June 13, 2026

The 1900 patent for acetylsalicylic acid, the chemical compound that became the world's most common pain reliever, known as Aspirin. Granted to FARBENFABRIKEN OF ELBERFELD Co in 1900 with 6 forward citations, and it is now in the public domain.

Key facts

Patent numberUS 644077
StatusExpired
FieldBiotech & Medicine
AssigneeFARBENFABRIKEN OF ELBERFELD Co
InventorFelix Hoffmann
Filed1898
Granted1900
Expires1918 (expired)
Times cited6
LitigationNone on record
Value · $14K$46KMinimal

Coverage

What does this patent actually cover?

This patent describes the chemical process for creating acetylsalicylic acid. It involves reacting salicylic acid with acetic anhydride to produce a stable, usable form of the drug. By acetylating the salicylic acid, the inventorinventorThe person who actually conceived the invention. Listed on the patent regardless of who owns it.Read more → created a compound that was significantly less irritating to the stomach than the raw salicylic acid used previously for pain and inflammation.

The gap

What does this patent NOT cover?

  • Does not cover the natural source of salicylic acid found in willow bark.
  • Does not cover other non-acetylated derivatives of salicylic acid.
  • Does not cover the specific brand name Aspirin, which was a trademarked term.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

What made this novel

The innovation was in the acetylation process, which successfully stabilized the compound for human consumption without the severe stomach side effects common to earlier treatments.

Acetyl salicylic acid.(Primary claim)pharmaceutical

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Bayer Aspirin

02

Generic acetylsalicylic acid tablets

03

Low-dose aspirin for cardiovascular health

Why it matters

The bigger picture

This patent marks the birth of the modern pharmaceutical industry. It transformed how society manages pain, fever, and inflammation, moving medicine from herbal extracts to standardized, mass-produced synthetic chemicals.

Filed

August 1, 1898

Granted

February 27, 1900

Market context

Who's building on this

Companies in this space

Bayer AG continues to be the primary steward of the Aspirin brand. Countless pharmaceutical companies worldwide produce generic versions of the drug now that the original patent has long expired.

Market impact

The patent enabled the creation of a massive global market for over-the-counter pain relief. It established the model for the modern drug industry, where synthetic chemical synthesis replaces traditional herbal remedies.

Claim 1 — Plain English

What this patent covers

This patent describes the chemical process for creating acetylsalicylic acid. It involves reacting salicylic acid with acetic anhydride to produce a stable, usable form of the drug. By acetylating the salicylic acid, the inventor created a compound that was significantly less irritating to the stomach than the raw salicylic acid used previously for pain and inflammation.

The clever bit

The innovation was in the acetylation process, which successfully stabilized the compound for human consumption without the severe stomach side effects common to earlier treatments.

What it does not cover

  • Does not cover the natural source of salicylic acid found in willow bark.
  • Does not cover other non-acetylated derivatives of salicylic acid.
  • Does not cover the specific brand name Aspirin, which was a trademarked term.

Patent Journey

From filing to expiry

PatentBrief Score

Impact Score

Limited data

Citation count

17/40

Early citations

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

0/20

Older than 20 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$14K$46K

Midpoint $29K · expired or expiring · industry ×3.0

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cited by later patents

6

later patents that build on this invention

View patents →

Cite this patent

Hoffmann, F. (1900). How Felix Hoffmann Invented Aspirin (U.S. Patent No. 644,077). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/644077/aspirin-acetylsalicylic-acid

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US644077"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4405829 · 1983

How RSA Public-Key Encryption Keeps Digital Messages Secret

This patent describes the foundational RSA algorithm, a method for securely sending messages where anyone can encrypt a message using a public key, but only the intended recipient can decrypt it using a secret private key.

Massachusetts Institute of Technology

US 4575330 · 1986

How 3D Printers Build Objects Layer by Layer from Liquid

This patent describes the foundational method for 3D printing, where a machine builds a three-dimensional object layer by layer by hardening a liquid material with light or other energy.

UVP Inc

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary

Common Questions

Frequently Asked Questions

What does How Felix Hoffmann Invented Aspirin cover?

The 1900 patent for acetylsalicylic acid, the chemical compound that became the world's most common pain reliever, known as Aspirin.

Who owns patent US 644077?

FARBENFABRIKEN OF ELBERFELD Co owns this patent, granted in 1900.

When does this patent expire?

This patent has expired and is now in the public domain — anyone can use the invention freely.

What is patent US 644077 cited by?

This patent has been cited by 6 later patents that build on its ideas.

What problem does this patent solve?

This patent marks the birth of the modern pharmaceutical industry. It transformed how society manages pain, fever, and inflammation, moving medicine from herbal extracts to standardized, mass-produced synthetic chemicals.

What does this patent NOT cover?

Does not cover the natural source of salicylic acid found in willow bark.

Patent monitoring

Get notified when FARBENFABRIKEN OF ELBERFELD Co files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: June 13, 2026 · PatentBrief is not a law firm and this is not legal advice.